Suchergebnisse - "De Cesaris, Francesco"

PubPharm (7)

1

Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine : A Prospective Multicenter Cohort Study

enthalten in: CNS drugs | 2023

von Caponnetto, V. | Russo, A. | Silvestro, M. | +42

2

Patterns of anti-CGRP mAbs use and variation of triptan consumption following treatment initiation : A descriptive drug utilization study in the Tuscany region, Italy

enthalten in: Headache | 2023

von Hyeraci, G. | Paoletti, O. | Iannone, L. | +4

3

Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria : A retrospective cohort study

enthalten in: Cephalalgia : an international journal of headache | 2023

von Iannone, L. | Burgalassi, A. | Vigani, G. | +4

4

Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine

enthalten in: Cephalalgia : an international journal of headache | 2022

von Iannone, L. | De Cesaris, F. | Ferrari, A. | +3

5

Predictors of sustained response and effects of the discontinuation of anti-calcitonin gene related peptide antibodies and reinitiation in resistant chronic migraine

enthalten in: European journal of neurology | 2022

von Iannone, L. | Fattori, D. | Benemei, S. | +3

6

Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score

enthalten in: CNS drugs | 2022

von Iannone, L. | Fattori, D. | Benemei, S. | +3

7

COVID-19 pneumonia during long-term migraine prophylaxis with fremanezumab : a case report

enthalten in: Internal and emergency medicine | 2021

von Iannone, L. | Geppetti, P. | Chiarugi, A. | +1

1
[1]